Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nipatha Issaro"'
Autor:
Suwisit Manmuan, Sukannika Tubtimsri, Nattaya Chaothanaphat, Nipatha Issaro, Mayuree H. Tantisira, Ponwit Manmuan
Publikováno v:
Research in Pharmaceutical Sciences, Vol 19, Iss 2, Pp 121-147 (2024)
Background and purpose: The anticancer drugs used for oral cancer treatment present many disadvantages, such as low solubility, low permeability, and poor bioavailability. However, the anticancer activity of ECa 233 has not been widely studied. There
Externí odkaz:
https://doaj.org/article/d9d3e117fc534d49b644caa0ff8fb232
Publikováno v:
Journal of Plant Biotechnology. 48:156-164
Autor:
Xiaokun Li, Haishan Tian, Sisi Huang, Nipatha Issaro, Vinothkumar Rajamanickam, Chao Jiang, Mi Zhou, Min Liu, Fenfang Wu, Zhaoxiang Fang, Lei Weng
Publikováno v:
Molecular immunology. 105
Fusion protein technology is used in biotechnology and medical developments. In this study, recombinant fusion proteins from enterovirus A71 (EV-A71) subgenotype B5, Thailand were designed based two surface proteins (VP1 and VP2) and an internal prot
Autor:
Nipatha Issaro, Chao Jiang, Shenghui Chu, Zhiyu Chen, Haishan Tian, Haiyan Hu, Sisi Huang, Min Liu
Publikováno v:
Biotechnology Journal. 13:1700411
The drug development of FGF7 has been restricted by its toxicity to the host, low expression, poor stability, and easy degradation. Recent studies have shown that Halo-tag-flanked recombinant human FGF7 can solve the problem of toxicity; however, its